Список литературы

1. Caro J.J. et al. Anemia as an independent prognostic factor for survival in patients with cancer: A systematic, quantitative review//Cancer. 2001. Vol. 91, N 12.

2. Hudis C.A. et al. rHuEPO and Treatment Outcomes: the Clinical Experience//Oncologist. 2004. Vol. 9, N S5.

3. Dicato M. Anemia in Cancer: Some Pathophysiological Aspects//Oncologist. 2003. Vol. 8, N S1.

4. Gilreath J.A., Stenehjem D.D., Rodgers G.M. Diagnosis and treatment of cancer-related anemia//American Journal of Hematology. 2014. Vol. 89, N 2.

5. Кулибаба Т.Г., Пчелин И.Ю., Слепых Л.А. Особенности анемического синдрома у онкологических пациентов//Juvenis Scientia. 2018. Vol. 9. P. 10 - 16.

6. Ludwig H. et al. The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients//Eur J Cancer. 2004. Vol. 40, N 15.

7. Ludwig Prof. H. et al. Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia//Annals of Oncology. 2013. Vol. 24, N 7.

8. Delarue R. et al. Iron Parameters and Relation To Prognosis In Elderly Patients With Aggressive Lymphoma Receiving First Line Immunochemotherapy: An Analysis Of The Lysa LNH 03-6B Study//Blood. 2013. Vol. 122, N 21.

9. Jansen V. Diagnosis of anemia-A synoptic overview and practical approach//Transfusion and Apheresis Science. 2019. Vol. 58, N 4.

10. Who, Chan M. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity//Geneva, Switzerland: World Health Organization. 2011.

11. Cella D, Kallich J, McDermott A, Xu X. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials//Ann Oncol. 2004. Vol. 15. P. 979 - 986.

12. Crawford J. et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy//Cancer. 2002. Vol. 95, N 4.

13. Demetri G.D. Anaemia and its functional consequences in cancer patients: Current challenges in management and prospects for improving therapy//Br J Cancer. 2001. Vol. 84, N SUPPL. 1.

14. Shah N., Andrews J., Goodnough L.T. Transfusions for anemia in adult and pediatric patients with malignancies//Blood Rev. 2015. Vol. 29, N 5.

15. Pasricha S.R. et al. Iron deficiency//The Lancet. 2021. Vol. 397, N 10270. P. 233 - 248.

16. Bermejo F., S. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases//World J Gastroenterol. 2009. Vol. 15, N 37. P. 4638.

17. Fertrin K.Y. Diagnosis and management of iron deficiency in chronic inflammatory conditions (CIC): Is too little iron making your patient sick?//Hematology (United States). 2020. Vol. 20, N 1.

18. Aapro M. et al. Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of I.V. iron//Annals of Oncology. 2012. Vol. 23, N 8.

19. Aapro M. et al. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines//Annals of Oncology. 2018. Vol. 29.

20. Bouri S., Martin J. Investigation of iron defi ciency anaemia//Clinical Medicine, Journal of the Royal College of Physicians of London. 2018. Vol. 18, N 3.

21. Esposito G. et al. Pernicious Anemia: The Hematological Presentation of a Multifaceted Disorder Caused by Cobalamin Deficiency//Nutrients. 2022. Vol. 14, N 8.

22. Green R., Datta Mitra A. Megaloblastic Anemias: Nutritional and Other Causes//Medical Clinics of North America. 2017. Vol. 101, N 2.

23. Долгов В.В., Луговская С.А., Морозова В.Т. П.М.Е. Лабораторная диагностика анемий. Москва, Триада. 2009; 147 с. n.d.

24. Buttarello M. Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how?//International Journal of Laboratory Hematology. 2016.

25. Hill A., Hill Q.A. Autoimmune hemolytic anemia//Hematology (United States). 2018. Vol. 2018, N 1.

26. Phillips J., Henderson A.C. Hemolytic anemia: Evaluation and differential diagnosis//Am Fam Physician. 2018. Vol. 98, N 6.

27. Batchelor E.K. et al. Iron deficiency in chronic kidney disease: Updates on pathophysiology, diagnosis, and treatment//Journal of the American Society of Nephrology. 2020. Vol. 31, N 3.

28. Fenaux P. et al. Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up//Annals of Oncology. 2021. Vol. 32, N 2.

29. Bohlius J. et al. Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update//Blood Advances. 2019. Vol. 3, N 8.

30. Li H.Y., Guo K. Blood Group Testing//Frontiers in Medicine. 2022. Vol. 9.

31. Жибурт Е.Б., Танкаева Х.С., Шестаков Е.А. Новые рекомендации по переливанию эритроцитов: что учесть службе трансфузиологии//Справочник заведующего КДЛ. 2020. Vol. 3. P. 40 - 53.

32. H., Bein G., Sachs U.J.H. Transfusion-Associated Graft-Versus-Host Disease//Transfusion Medicine Reviews. 2009. Vol. 23, N 1.

33. Abdallah R., Rai H., Panch S.R. Transfusion Reactions and Adverse Events//Clinics in Laboratory Medicine. 2021. Vol. 41, N 4.

34. King K.E. et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs//Transfusion. 2004. Vol. 44, N 1.

35. Dzik W.H. Leukoreduction of blood components//Current Opinion in Hematology. 2002. Vol. 9, N 6.

36. Dwyre D.M., Holland P.V. Transfusion-associated graft-versus-host disease//Vox Sanguinis. 2008. Vol. 95, N 2.

37. Павлов А.Д., Морщакова Е.Ф., Румянцев А.Г. Эритропоэз, эритропоэтин, железо. М.: ГЭОТАР-Медиа. 2011. 304 p.

38. Hedley B.D., Allan A.L., Xenocostas A. The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression//Clinical Cancer Research. 2011. Vol. 17, N 20.

39. Bennett C.L. et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia//JAMA. 2008. Vol. 299, N 8.

40. Железодефицитная анемия. Клинические рекомендации, 2021. URL: cr.minzdrav.gov.ru/recommend/669.

41. J.C. et al. Treatment of autoimmune hemolytic anemia: Real world data from a reference center in Mexico//Blood Res. 2019. Vol. 54, N 2.

42. Hill Q.A., Hill A., Berentsen S. Defining autoimmune hemolytic anemia: A systematic review of the terminology used for diagnosis and treatment//Blood Advances. 2019. Vol. 3, N 12.